петък, 23 октомври 2020 г.

Weekly Update: New diabetes clinical trial (15 items)

New diabetes clinical trial: Effect of WF10 (TCDO) on HbA1c Values in Diabetic Foot Ulcer Patients

Published on: May 04, 2020 at 07:00PM
Conditions:   Diabetic Foot Ulcer (DFU);   Uncontrolled Diabetes With Foot Ulcer
Intervention:   Drug: WF10
Sponsors:   Srinakharinwirot University;   Oxo Chemie(Thailand) Co.,Ltd.;   Altermed Co.,Ltd.
Recruiting
https://clinicaltrials.gov/ct2/show/NCT04372355?term=diabetes&sfpd_d=14 May 04, 2020 at 03:20PM

via ClinicalTrials.gov


New diabetes clinical trial: Effect of Manual Therapy on Tibiotarsal Joint Mobility in Diabetic Individuals

Published on: May 04, 2020 at 07:00PM
Condition:   Diabetes Complications
Interventions:   Procedure: High Velocity Low Amplitude manipulation (HVLA);   Procedure: Care assessment and guidance
Sponsor:   University of Sao Paulo
Completed
https://clinicaltrials.gov/ct2/show/NCT04372810?term=diabetes&sfpd_d=14 May 04, 2020 at 03:20PM

via ClinicalTrials.gov


New diabetes clinical trial: Clinical and Metabolic Characterization of Long-term Courses of Obesity Patients

Published on: May 05, 2020 at 07:00PM
Condition:   Obesity
Intervention:   Procedure: Bariatric surgery
Sponsor:   University Hospital Tuebingen
Recruiting
https://clinicaltrials.gov/ct2/show/NCT04375371?term=diabetes&sfpd_d=14 May 05, 2020 at 02:20PM

via ClinicalTrials.gov


New diabetes clinical trial: GABA to Beta-cell Regeneration

Published on: May 05, 2020 at 07:00PM
Condition:   Diabetes Mellitus, Type 1
Intervention:   Drug: GABA
Sponsor:   Ministry of Health and Population, Egypt
Completed
https://clinicaltrials.gov/ct2/show/NCT04375020?term=diabetes&sfpd_d=14 May 05, 2020 at 02:20PM

via ClinicalTrials.gov


New diabetes clinical trial: Effect of Dulaglutide on Improve Glycemic Variability With Type 2 Diabetes

Published on: May 05, 2020 at 07:00PM
Condition:   Diabetes Mellitus, Type 2
Intervention:   Drug: Dulaglutide 1.5Mg/0.5Ml Inj Pen
Sponsor:   Shanghai Zhongshan Hospital
Not yet recruiting
https://clinicaltrials.gov/ct2/show/NCT04374578?term=diabetes&sfpd_d=14 May 05, 2020 at 02:20PM

via ClinicalTrials.gov


New diabetes clinical trial: Study to Assess the Efficacy and Safety of Liraglutide in the Treatment of Type 2 Diabetes

Published on: May 05, 2020 at 07:00PM
Condition:   Type 2 Diabetes
Interventions:   Drug: Victoza®.;   Drug: Metformin Hydrochloride;   Drug: TQZ2451
Sponsor:   Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Not yet recruiting
https://clinicaltrials.gov/ct2/show/NCT04373967?term=diabetes&sfpd_d=14 May 05, 2020 at 02:20PM

via ClinicalTrials.gov


New diabetes clinical trial: High vs Low Dose Vitamin D in Patients With Diabetic Peripheral Neuropathy

Published on: May 06, 2020 at 07:00PM
Conditions:   Diabetes Type 2;   Diabetic Neuropathies;   Vitamin D Deficiency
Intervention:   Drug: Vitamin D
Sponsors:   Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health;   Tameside Hospital NHS Foundation Trust
Completed
https://clinicaltrials.gov/ct2/show/NCT04377399?term=diabetes&sfpd_d=14 May 06, 2020 at 02:49PM

via ClinicalTrials.gov


New diabetes clinical trial: Colchicine Has Anti-diabetic Effect

Published on: May 06, 2020 at 07:00PM
Condition:   Treatment Adherence
Intervention:   Drug: Colchicine Tablets
Sponsor:   Ministry of Health and Population, Egypt
Completed
https://clinicaltrials.gov/ct2/show/NCT04377321?term=diabetes&sfpd_d=14 May 06, 2020 at 02:49PM

via ClinicalTrials.gov


New diabetes clinical trial: Clinical and Echocardiographic Management of Patients With Heart Failure and Diabetes: SCODIAC Follow up Study

Published on: May 06, 2020 at 07:00PM
Conditions:   Diabetes;   Heart Failure
Intervention:   Drug: Antidiabetic
Sponsor:   Federico II University
Completed
https://clinicaltrials.gov/ct2/show/NCT04375943?term=diabetes&sfpd_d=14 May 06, 2020 at 02:49PM

via ClinicalTrials.gov


New diabetes clinical trial: β-cell Function and Insulin Sensitivity in Patients With Cystic Fibrosis

Published on: May 07, 2020 at 07:00PM
Condition:   Cystic Fibrosis-related Diabetes
Intervention:   Behavioral: therapeutic optimization
Sponsor:   Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Not yet recruiting
https://clinicaltrials.gov/ct2/show/NCT04379726?term=diabetes&sfpd_d=14 May 07, 2020 at 02:49PM

via ClinicalTrials.gov


New diabetes clinical trial: Impact of Acetaminophen on Performance of Guardian™ Sensor (3) in Adults

Published on: May 07, 2020 at 07:00PM
Conditions:   Type 1 Diabetes Mellitus;   Type 2 Diabetes Mellitus
Intervention:   Device: One time acetaminophen ingestion while wearing Guardian™ Sensor (3) connected to a Guardian™ Connect Transmitter
Sponsor:   Medtronic Diabetes
Not yet recruiting
https://clinicaltrials.gov/ct2/show/NCT04378114?term=diabetes&sfpd_d=14 May 07, 2020 at 02:49PM

via ClinicalTrials.gov


New diabetes clinical trial: Measurement Algorithm Control and Optimization With Subsequent Performance Evaluation of Sanmina Non-invasive Biosensors During a Standardized Meal Test in Patients With Diabetes Mellitus Type 1 and Type 2

Published on: May 07, 2020 at 07:00PM
Condition:   Diabetes Mellitus
Intervention:   Device: Sanmina Biosensor
Sponsors:   Sciema UG;   Sanmina
Completed
https://clinicaltrials.gov/ct2/show/NCT04379427?term=diabetes&sfpd_d=14 May 07, 2020 at 02:49PM

via ClinicalTrials.gov


New diabetes clinical trial: Relation Between Plasma Apelin Level and Diabetic Nephropathy in Type 2 Diabetes Patients.

Published on: May 08, 2020 at 07:00PM
Condition:   Diabetic Nephropathies
Intervention:   Diagnostic Test: plasma Apelin level
Sponsor:   Cairo University
Completed
https://clinicaltrials.gov/ct2/show/NCT04380584?term=diabetes&sfpd_d=14 May 08, 2020 at 01:49PM

via ClinicalTrials.gov


New diabetes clinical trial: Effect of Postprandial Insulin Administration of Faster-acting Insulin Analogue Versus Pre-prandial Administration of Acting-insulin Analogue in Cystic Fibrosis Related Diabetes

Published on: May 08, 2020 at 07:00PM
Condition:   Cystic Fibrosis-related Diabetes
Interventions:   Drug: A-F-A-F (NovoRapid-FIASP-NovoRapid-FIASP);   Drug: F-A-F-A (FIASP-NovoRapid-FIASP-NovoRapid)
Sponsor:   University Hospital, Strasbourg, France
Not yet recruiting
https://clinicaltrials.gov/ct2/show/NCT04381429?term=diabetes&sfpd_d=14 May 08, 2020 at 01:49PM

via ClinicalTrials.gov


New diabetes clinical trial: Effects of an Activity Control System in Patients With Diabetes: a Randomized Controlled Trial

Published on: May 08, 2020 at 07:00PM
Condition:   Diabetes Mellitus, Type 2
Intervention:   Other: Beprevent
Sponsor:   Universidad Católica San Antonio de Murcia
Not yet recruiting
https://clinicaltrials.gov/ct2/show/NCT04380844?term=diabetes&sfpd_d=14 May 08, 2020 at 01:49PM

via ClinicalTrials.gov


Няма коментари:

Публикуване на коментар